Background
==========

Recent *in silico*surveys showed that most bacterial genomes contain interrupted coding sequences (ICDSs) \[[@B1]-[@B3]\]. These ICDSs generally result from the insertion or deletion of nucleotides, affecting the frame read and splitting the original coding sequence into two or more smaller open reading frames. These mutations may also result in a shift in reading frame, thereby altering the carboxy-terminus of the protein. ICDSs may be present in genes with known or unknown functions, or in hypothetical open reading frames \[[@B4]\]. Reported prokaryotic genomes have a mean of 74 ICDSs per genome, corresponding to 1 to 5% of the genes present, irrespective of genome size or GC content \[[@B2],[@B3]\]. One of the few exceptions is the genome of *M. leprae*, which contains about 30% ICDSs, frequently described as pseudogenes \[[@B2],[@B5]\]. The accumulation of mutations in this species is thought to be due to the loss of the proofreading activity of the DnaQ subunit of DNA polymerase III \[[@B6]\]. A similar sort of reductive evolution is also observed in the case of *M. ulcerans*\[[@B7]\] or for species of the genus *Rickettsiales*\[[@B8]\]. ICDSs may correspond to authentic mutations, generally resulting in a loss of function, but may in some cases reflect sequencing errors. These sequencing errors are misleading when conducting genomic analysis, but have been shown to account for only some of the detected ICDSs \[[@B4],[@B9]-[@B12]\]. Most ICDSs correspond to authentic mutations and can therefore be compared between strains, making it possible to explore conserved and unique mutation events.

The availability of complete genomes sequences for genetically related organisms has facilitated comparative analyses of ICDSs. This simple concept, which has not been reported before, enables to investigate evolutionary relationship between isolates or species. In this study, we took the finished genome of two mycobacterial species as a model: *M. tuberculosis*, which causes tuberculosis in humans, and *M. bovis*, which principally causes tuberculosis in ruminants. We also studied six phylogenetically distinct isolates of *M. tuberculosis*-- H37Rv, CDC1551, Haarlem, F11, C \[[@B13]\], and 210 (a representative of the W-Beijing family) and *M. africanum*, a species of the *M. tuberculosis*complex for which the genome sequence is still at the assembly step. These isolates are different from each other as they belong to distinct evolutionary branches of the *M. tuberculosis*species, *sensu stricto (s.s)*, yet more closely related to each other than to the more distantly related members of the *M. tuberculosis*complex (*M. africanum*, *M. bovis*, *M. microti*and *M. pinnipedii*) \[[@B14]\]. The W-Beijing family is a clonal group of highly successful *M. tuberculosis*strains associated with multiple outbreaks \[[@B15]\]. This family is one of the oldest lineages to diverge as determined by single nucleotide polymorphism (SNP) and region of deletion analysis \[[@B14]\]. In contrast, H37Rv, the first *M. tuberculosis*strain to be completely sequenced is believed to be one of the most recent (youngest) lineages of *M. tuberculosis*\[[@B14],[@B16]\]. Strain CDC1551 belongs to a lineage that branched between the W-Beijing and the H37Rv isolates. Overall these three isolates represent 3 different genetic groups of the species \[[@B14]-[@B17]\]. These isolates have been studied in detail and display differences in genotype \[[@B14],[@B18]\], phenotype and virulence properties \[[@B19],[@B20]\]. By comparing the open reading frames containing frameshifts in these organisms, we showed that ICDSs could be classified as \"common to all strains\" or \"lineage- or strain-specific\". The common ICDSs probably correspond to mutations occurring before the divergence of the isolates, whereas lineage- or strain-specific ICDSs correspond to more recently acquired mutations. Thus, ICDS investigation can be used to characterize the molecular scars of evolutionary relationships between organisms and may well provide a unique molecular signature for a particular strain or species, complementary to single nucleotide polymorphism (SNP) and other molecular markers analyses for the characterization of strain variation \[[@B18],[@B21]\]. We also show that ICDS formation is not associated with mutation in the promoter region. The present data suggests that promoter extinction is not a major event in the \"pseudogenization\" process. To experimentally prove that ICDSs comparison is a powerful phylogenomic tool, we analyzed 21 clinical *M. tuberculosis*isolates for their ICDS content. We showed that the W-Beijing lineage differs from the other TB phyla by a lower number of common ICDSs, confirming early divergence with *M. tuberculosis s.s*strains. ICDS characterization in addition to phylogenetic investigations or typing can be used to select strains or phenotypes for studies of particular phenotypic characters, such as virulence. Indeed, as frameshift acquisition may lead to a loss of function, researchers should consider the possible presence of ICDS before choosing a strain or species for investigating a particular phenotype.

Results
=======

Detecting the molecular scars of evolution in *M. tuberculosis*and in *M. bovis*
--------------------------------------------------------------------------------

Comparative analyses of frameshift-containing genes require the complete genome sequences of closely related organisms. The TB complex, which includes two recently sequenced species and at least 6 accessible strains, is therefore a highly suitable model. We investigated ICDSs in *M. tuberculosis*and in *M. bovis*. The genome sequence of *M. tuberculosis*H37Rv has been available since 1998 and has recently been re-annotated \[[@B22],[@B23]\]. The genome sequences of *M. tuberculosis*strain CDC1551 and *M. bovis*have been characterized independently \[[@B18],[@B24]\]. The great advantage of studying this model system is that the evolution of these two species and the phylogenetic links between them are well documented \[[@B25]\]. The *M. tuberculosis*genomes (CDC1551 and H37Rv) have nucleotide sequences more than 99.95 % identical to that of *M. bovis*\[[@B18],[@B24]\]. The three genomes were screened for the presence of ICDSs. To this end, the genomic sequences of each predicted ICDS \[[@B3]\] were extracted for each strain or species and compared between them. Each common or specific ICDS was then analyzed manually to characterize the molecular event leading to the detected frameshift. The genome of H37RV contains 113 ICDSs, whereas CDC1551 has 137 ICDSs and *M. bovis*has 134 ICDSs, corresponding to about 2% of the total coding sequences \[[@B3]\]. These organisms have similar numbers of ICDSs, but the alterations do not always affect the same genes. We therefore investigated whether some of these ICDSs were common to all three organisms. We compared the nucleotide and deduced amino-acid sequences of each frameshift-containing open reading frame in the three organisms. We found that 81 of the frameshift-containing genes were common to all three strains (Figure [1A](#F1){ref-type="fig"}, Table [1](#T1){ref-type="table"}), and were identical at the molecular level. The proteins affected by these frameshifts included proteins of unknown function as well as annotated and/or characterized proteins (Table [1](#T1){ref-type="table"}). The fact that these three mycobacterial genomes were sequenced and assembled independently suggests that these 81 common ICDSs correspond to authentic frameshift-containing genes rather than sequencing errors. These results indicate that these 81 ICDSs correspond to frameshifts acquired before the splitting of the *M. tuberculosis*and *M. bovis*species (Table [1](#T1){ref-type="table"}). Alternatively, the same 81 genetic mutations may result from convergent evolution and hence have occurred independently in all three genomes, a highly unlikely scenario.

![**A-**Schematic representation of the ICDSs common to *M. tuberculosis*H37Rv, CDC1551 and *M. bovis*AF2122/97 or specific to one of these strains. The total number of ICDSs is indicated. **B-**Schematic representation of the ICDSs of *M. bovis*BCG 1173P2 compared to the other analyzed strains.](1471-2148-8-78-1){#F1}

###### 

List of the 81 ICDSs common to *M. tuberculosis*H37Rv, CDC1551, *M. bovis*AF2122/97 and *M. africanum*GM041182.

  *M. tub*H37Rv                                *M. tub*CDC1551   *M. bov*AF2122/97   *M. bov*BCG 1173P2   *M. africanum*   Putative function                                Functional classification
  -------------------------------------------- ----------------- ------------------- -------------------- ---------------- ------------------------------------------------ ---------------------------
  0002 (Rv0151c *588 aa*)                      0004              0006                0109                 ICDS             PE family protein                                PE/PPE
  0003 (Rv0152c *525 aa*)                      0005              0007                0004                 ICDS             PE family protein                                PE/PPE
  0007 (Rv0366c *197 aa*-- Rv0367c *129 aa*)   0011              0010                0110                 ICDS             Conserved hypothetical                           Unknown
  0009 (Rv0393 *441 aa*)                       0012              0011                0008                 ICDS             Conserved hypothetical                           Unknown
  0010 (Rv0520 *116 aa*-- Rv0521 *101 aa*)     0014              0013                0012                 ICDS             Dimethylglycine N-methyltransferase              Intermediary metabolism
  0012 (Rv0601c *157 aa*)                      0017              0018                0016                 ICDS°            Two-component sensor kinase                      Regulation
  0014 (Rv0635 *158 aa*-- Rv0636 *142 aa*)     0019              0020                0111                 ICDS             Conserved hypothetical                           Unknown
  0015 (Rv0636 *142 aa*-- Rv0637 *166 aa*)     0020              0021                0112                 ICDS             Conserved hypothetical                           Unknown
  0017 (Rv0724A *112 aa*-- Rv0725c *301 aa*)   0022              0023                0020                 ICDS             Conserved hypothetical                           Unknown
  0020 (Rv0865 *160 aa*)                       0026              0085                0113                 ICDS             Molybdopterin biosynthesis protein               Intermediary metabolism
  0021 (Rv0890c *882 aa*-- Rv0891c *285 aa*)   0027              0025                0114                 ICDS             Transcriptional regulator                        Regulation
  0023 (Rv1034c *130 aa*-- Rv1035c *228 aa*)   0030              0030                0031                 ICDS             Transposase                                      IS/phage
  0024 (Rv1035c *228 aa*-- Rv1036c *112 aa*)   0031              0031                0032                 ICDS             Transposase                                      IS/phage
  0025 (Rv1041c *287 aa*-- Rv1042c *135 aa*)   0032              0086                0034                 ICDS             Transposase                                      IS/phage
  0026 (Rv1104 *229 aa*)                       0034              0087                0115                 ICDS             Esterase                                         Intermediary metabolism
  0027 (Rv1104 *229 aa*)                       0035              0088                0037                 ICDS             Esterase                                         Intermediary metabolism
  0028 (Rv1105 *171 aa*)                       0036              0033                0036                 ICDS             Para-nitrobenzyl esterase                        Intermediary metabolism
  0029 (Rv1119c *49 aa*- Rv1120c*164 aa*)      0037              0034                0039                 ICDS             Conserved hypothetical                           Unknown
  0030 (Rv1136 *113 aa*)                       0039              0089                0040                 ICDS             Enoyl-CoA                                        Lipid metabolism
  0032 (Rv1149 *135 aa*-- Rv1150 *183 aa*)     0041              0090                0041                 ICDS             Transposase                                      IS/phage
  0033 (Rv1163 *201 aa*-- Rv1164 *246 aa*)     0042              0035                0116                 ICDS             Nitrate reductase NarI-J                         Intermediary metabolism
  0035 (Rv1203c *194 aa*-- Rv1204c *562 aa*)   0044              0036                0043                 ICDS             Conserved hypothetical                           Unknown
  0036 (Rv1413 *171 a*)                        0046              0041                0047                 ICDS             Conserved hypothetical                           Unknown
  0040 (Rv1662 *1602 aa*-- Rv1663 *502 aa*)    0053              0043                0117                 ICDS             Polyketide synthase Pks8/17                      Lipid metabolism
  0041 (Rv1687c *255 aa*)                      0054              0132                0128                 ICDS°            ATP binding protein, ABC transporter             Cell wall, process
  0043 (Rv1735c *166 aa*)                      0056              0112                0050                 ICDS             Malic acid transport protein                     Cell wall, process
  0046 (Rv1878 *450 aa*)                       0061              0052                0118                 ICDS°            Glutamine synthetase GlnA3                       Intermediary metabolism
  0047 (Rv1888A *58 aa*-- Rv1889c *118 aa*)    0062              0053                0119                 ICDS             Conserved hypothetical                           Unknown
  0048 (Rv1931c *259 aa*)                      0064              0054                0058                 ICDS             Conserved hypothetical                           Unknown
  0049 (Rv1949c *319 aa*-- Rv1950c *63 aa*)    0065              0055                0059                 ICDS             Conserved hypothetical                           Unknown
  0050 (Rv2013 *159 aa*-- Rv2014 *196 aa*)     0066              0056                0061                 ICDS°            Transposase                                      IS/phage
  0051 (Rv2086 *201 aa*)                       0067              0093                0062                 ICDS             Conserved hypothetical                           Unknown
  0052 (Rv2086 *201 aa*-- Rv2087 *76 aa*)      0068              0058                0063                 ICDS             Conserved hypothetical                           Unknown
  0053 (Rv2087 *76 aa*)                        0069              0094                0064                 ICDS             Conserved hypothetical                           Unknown
  0054 (Rv2095c *316 aa*-- Rv2096 *332 aa*)    0070              0133                0129                 ICDS             Conserved hypothetical                           Unknown
  0058 (Rv2321 *182 aa*-- Rv2322c *221 aa*)    0074              0060                0067                 ICDS             Ornithine aminotransferase RocD1                 Intermediary metabolism
  0059 (Rv2325 *282 aa*-- Rv2326c *697 aa*)    0075              0096                0120                 ICDS             Conserved hypothetical                           Unknown
  0060 (Rv2331 *129 aa*)                       0076              0134                0130                 ICDS             Hypothetical                                     Unknown
  0061 (Rv2337 *372 aa*-- Rv2338c *318 aa*)    0077              0097                0068                 ICDS             Conserved hypothetical                           Unknown
  0062                                         0081              0065                0076                 ICDS             Hydrogenase nickel incorporation protein HypB    Intermediary metabolism
  0063 (Rv2877c *287 aa*-- Rv2878c *173 aa*)   0082              0099                0077                 ICDS°            Conserved hypothetical                           Unknown
  0065 (Rv2943A *177 aa*-- Rv2944 *239 aa*)    0083              0066                0079                 ICDS             Transposase                                      IS/phage
  0068 (Rv3128c *338 aa*)                      0088              0068                0082                 ICDS             Conserved hypothetical                           Unknown
  0069 (Rv3152 *410 aa*-- Rv3153 *211 aa*)     0089              0100                0121                 ICDS             NADH dehydrogenase I                             Intermediary metabolism
  0070 (Rv3172c *160 aa*)                      0090              0069                0083                 ICDS             Conserved hypothetical                           Unknown
  0071 (Rv3200c *355 aa*)                      0091              0101                0122                 ICDS             Hypothetical                                     Unknown
  0075 (Rv3349c *246 aa*)                      0100              0102                0085                 ICDS°            Transposase                                      IS/phage
  0076 (Rv3351c *264 aa*-- Rv3352c *123 aa*)   0101              0071                0088                 ICDS             Oxidoreductase                                   Intermediary metabolism
  0077 (Rv3352c *123 aa*-- Rv3353c *86 aa*)    0102              0072                0089                 ICDS             Oxidoreductase                                   Intermediary metabolism
  0079 (Rv3419c *344 aa*)                      0104              0135                0131                 ICDS             O-sialoglycoprotein endopeptidase                Intermediary metabolism
  0080 (Rv3420c *158 aa*-- Rv3421c *211 aa*)   0105              0104                0092                 ICDS°            Conserved hypothetical                           Unknown
  0083                                         0108              0107                0095                 ICDS             Transposase                                      IS/phage
  0084 (Rv3636 *115 aa*-- Rv3637 *166 aa*)     0111              0076                0097                 ICDS             Transposase                                      IS/phage
  0087 (Rv3741c *224 aa*-- Rv3742c *131 aa*)   0114              0078                0099                 ICDS°            Aromatic-ring hydroxylase                        Intermediary metabolism
  0088 (Rv3770A *61 aa*-- Rv3770B *64 aa*)     0115              0079                0100                 ICDS°            Transposase                                      IS/phage
  0089 (Rv 3844 *164 aa*-- Rv3845 *120 aa*)    0116              0136                0132                 ICDS             Transposase                                      IS/phage
  0090 (Rv3866 *283 aa*-- Rv3867 *183 aa*)     0117              0109                0123                 ICDS             Conserved hypothetical                           Unknown
  0091 (Rv3880c *115 aa*-- Rv3881 *460 aa*)    0118              0137                0133                 ICDS             Conserved hypothetical                           Unknown
  0095 (Rv3900c *311 aa*)                      0122              0083                0124                 ICDS             Conserved hypothetical                           Unknown
  0097 (Rv3913 *335 aa*-- Rv3914 *116 aa*)     0123              0111                0001                 ICDS             Thioredoxin reductase                            Intermediary metabolism
  0098                                         0124              0032                0035                 ICDS             Conserved hypothetical                           Unknown
  0099 (Rv3386 *234 aa*-- Rv3387 *225 aa*)     0125              0103                0090                 ICDS             Transposase                                      IS/phage
  0100 (Rv0342 *640 aa*-- Rv0343 *493 aa*)     0126              0009                0125                 ICDS             Isoniazid inductible gene protein                Cell wall, process
  0101 (Rv0763c *69 aa*-- Rv0764c *451 aa*)    0127              0084                0126                 ICDS             Cytochrome P450                                  Intermediary metabolism
  0102 (Rv1858 *264 aa*-- Rv1859 *369 aa*)     0128              0092                0127                 ICDS             Molybdenum transport ABC transporter             Cell wall, process
  0103 (Rv0449c *439 aa*)                      0129              0113                0010                 ICDS             Conserved hypothetical                           Unknown
  0104 (Rv0471c *162 aa*)                      0130              0114                0011                 ICDS             Hypothetical                                     Unknown
  0105 (Rv0859 *403 aa*-- Rv0860 *720 aa*)     0131              0115                0024                 ICDS°            Acyl-CoA thiolase FadA and dehydrogenase FadB    Lipid metabolism
  0106 (Rv0880 *143 aa*-- Rv0881 *288 aa*)     0132              0116                0025                 ICDS°            Transcriptional regulator                        Information pathway
  0107 (Rv0997 *143 aa*)                       0133              0117                0029                 ICDS             Hypothetical                                     Unknown
  0108 (Rv1041c *287 aa*-- Rv1042c *135 aa*)   0134              0118                0033                 ICDS°            Transposase                                      IS/phage
  0109 (Rv1104 *229 aa*-- Rv1105 *171 aa*)     0135              0119                0038                 ICDS             Para-nitrobenzyl esterase                        Intermediary metabolism
  0110 (Rv1221 *257 aa*-- Rv1222 *154 aa*)     0136              0120                0044                 ICDS             Alternative sigma factor SigE                    Information pathway
  0111 (Rv1752c *149 aa*)                      0137              0121                0051                 ICDS             Conserved hypothetical                           Unknown
  0112 (Rv1961 *164 aa*)                       0138              0122                0060                 ICDS             Hypothetical                                     Unknown
  0113 (Rv2309c *151 aa*)                      0139              0123                0066                 ICDS             Integrase                                        Information pathway
  0114 (Rv2420c *127 aa*-- Rv2421c *211 aa*)   0140              0124                0070                 ICDS             nicotinate-nucleotide adenylyltransferase NadD   Intermediary metabolism
  0115 (Rv2732c *205 aa*-- Rv2733c *512 aa*)   0141              0125                0073                 ICDS             Conserved hypothetical                           Unknown
  0116 (Rv2922A *94 aa*-- Rv2923c *137 aa*)    0142              0126                0078                 ICDS             Acylphosphatase AcyP                             Intermediary metabolism
  0117 (Rv3774 *274 aa*-- Rv3775 *274 aa*)     0143              0127                0101                 ICDS°            Enoyl-CoA hydratase EchA21 and lipase LipE       Lipid metabolism
  0119 (Rv2599 *143 aa*-- Rv2600 *133 aa*)     0144              0098                0134                 ICDS°            Conserved hypothetical                           Unknown

ICDS number (variable, according to the strain), the size of the predicted protein and its putative function are indicated. The corresponding ORF numbers in *M. tuberculosis*H37Rv are indicated in brackets. \"°\" indicates ICDSs containing additional mutations with respect to *M. tuberculosis*H37Rv, CDC1551 and *M. bovis*AF2122/97.

The two *M. tuberculosis s.s*strains were found to have 19 additional common ICDSs, raising their total number to 100 (Figure [1A](#F1){ref-type="fig"}, Table [2](#T2){ref-type="table"}). This suggests that the 19 additional mutations common to these two strains but not to *M. bovis*were acquired post-divergence of *M. tuberculosis*and *M. bovis*. One ICDS in *M. bovis*(ICDS0046, Mb1789c-Mb1790c) was present in *M. tuberculosis*CDC1551 (ICDS0057, MT1807) but not in *M. tuberculosis*H37Rv (Rv1759c). This mutation (deletion of one G) was identical in the *M. bovis*and *M. tuberculosis*CDC1551 strains, but an additional mutation was present close to this mutation in the *M. bovis*genome. One ICDS in *M. bovis*(ICDS0128, Mb3813-Mb3814) was also present in *M. tuberculosis*H37Rv (ICDS0118, Rv3784-Rv3785) but not in *M. tuberculosis*CD1551 (MT3893) (Table [2](#T2){ref-type="table"}).

  *M. tub*H37Rv                                  *M. tub*CDC1551          M. bovis AF2122/97    *M. tub*210       *M. africanum*       Putative function                           Functional classification
  ---------------------------------------------- ------------------------ --------------------- ----------------- -------------------- ------------------------------------------- -------------------------------
  0001 (Rv0095c *136 aa*)                        0003                     Mb0098c *260 aa*      ICDS              Not Found            Conserved hypothetical                      Unknown
  0005 (Rv0325 *74 aa*-- Rv0326 *151 aa*)        0010                     Mb0333 *229 aa*       FL                FL                   Hypothetical                                Unknown
  0011 (Rv0590 *275 aa*-- Rv0590A 9 0 *84 aa*)   0016                     Mb0605 *343 aa*       FL                FL                   MCE-family protein                          Virulence, detox, adapt
  0013 (Rv0618 *231 aa*-- Rv0619 1 8 *181 aa*)   0018                     Mb0635 *394 aa*       ICDS              FL                   Galactose-1-phosphate uridylyltransferase   Intermediary metabolism
  0022 (Rv0924c *428 aa*-- Rv0925c *245 aa*)     0028                     Mb0948c *684 aa*      ICDS              ICDS                 Manganese transport protein MntH            Cell wall, process
  0031 (Rv1145 *303 aa*-- Rv1146 *470 aa*)       0040                     Mb1177 *781 aa*       FL                FL                   Transmembrane transport protein MmpL13      Cell wall, process
  0037 (Rv1503c *182 aa*-- Rv1504c *199 aa*)     0048                     Mb1542c *382 aa*      ICDS              FL                   Conserved hypothetical                      Unknown
  0038 (Rv1549 *175 aa*-- Rv1550 *571 aa*)       0051                     Mb1576 *647 aa*       ICDS              FL                   Fatty-acid-coA ligase FadD11                Lipid metabolism
  0039 (Rv1553-Rv1554 *247 aa -- 126 aa*)        0052                     Mb1579 *374 aa*       ICDS°             ICDS°                Fumarate reductase                          Intermediary metabolism
  0045 (Rv1792 *59 aa*)                          0058                     Mb1820 *98 aa*        ICDS              FL                   ESAT-6-like protein EsxM                    Cell wall, process
  0055 (Rv2227 *233 aa*)                         0072                     Mb2252 *124 aa*       ICDS              FL                   Conserved hypothetical                      Unknown
  0066 (Rv2946c *1616 aa*-- Rv2947 *496 aa*)     0084                     Mb2971c *2112 aa*     FL                FL                   Polyketide synthase Pks15/1                 Lipid metabolism
  0067 (Rv2974c *470 aa*-- Rv2975c *84 aa*)      0085                     Mb2999c *553 aa*      FL                FL                   Conserved hypothetical                      Unknown
  0072 (Rv3233c *196 aa*-- Rv3234c *271 aa*)     0092                     Mb3262c *469 aa*      FL                FL                   Conserved hypothetical                      Unknown
  0073 (Rv3337 *128 aa*-- Rv3338 *214 aa*)       0094                     Mb3370 *297 aa*       ICDS              FL                   Conserved hypothetical                      Unknown
  0078 (Rv3373 *213 aa*-- Rv3374 *82 aa*)        0103                     Mb3408 *296 aa*       ICDS              FL                   Enoyl-CoA hydratase EchA18                  Lipid metabolism
  0085 (Rv3725 *309 aa*)                         0112                     Mb3752 *333 aa*       FL                FL                   Oxidoreductase                              Intermediary metabolism
  0086 (Rv3738c *315 aa*-- Rv3739c *77 aa*)      0113                     Not determined        ICDS              ICDS                 PPE family protein                          PE/PPE
  0094 (Rv3897c *210 aa*-- Rv3898c *110 aa*)     0121                     Mb3927c *329 aa*      FL                FL                   Conserved hypothetical                      Unknown
                                                                                                                                                                                   
  ***M. tub*H37Rv**                              **M. bovis AF2122/97**   ***M. tub*CDC1551**   ***M. tub*210**   ***M. africanum***   **Putative function**                       **Functional classification**
                                                                                                                                                                                   
  0118 (Rv3784 *326 aa*-- Rv3785 *357 aa*)       0128                     MT3893 *712 aa*       NT                ICDS                 NAD-dependent epimerase/dehydratase         Information pathway
                                                                                                                                                                                   
  ***M. tub*CDC1551**                            **M. bovis AF2122/97**   ***M. tub*H37Rv**     ***M. tub*210**   ***M. africanum***   **Putative function**                       **Functional classification**
                                                                                                                                                                                   
  0057 (MT1806 *820 aa*-- MT1807 *94 aa*)        0046                     Rv1759c *914 aa*      NT                NT                   PE_PGRS family protein                      PE/PPE

List of the 19 ICDSs common to *M. tuberculosis*H37Rv and CDC1551, the ICDSs common to *M. tuberculosis*H37Rv and *M. bovis*AF2122/97 and the ICDSs common to *M. tuberculosis*CDC1551 and *M. bovis*AF2122/97. ICDS number (variable, according to strain), the size of the predicted protein and its putative function are indicated. The genes that do not contain a frameshift in either *M. tuberculosis*strain 210 and in *M. africanum*and that correspond to a full-length ORF are noted \"FL\". \"NT\", not tested.

The availability of genomic resources for *M. tuberculosis*is increasing exponentially. This enabled us to investigate the presence or absence of these shared ICDSs in the Haarlem, F11, and C strains, the genomic sequences of which are currently at the assembly stage at the Broad Institute \[[@B26]\]. As the sequence of these genomes is in progress, the total number of frameshift-containing genes in these genomes cannot yet be accurately determined; nonetheless, it is possible to check whether the 81 ICDSs present in *M. bovis*and in other *M. tuberculosis*strains are present in these strains. All 81 ICDSs common to all three strains previously tested were also present in Haarlem and F11 strains, while 79 were present in the C strain (corresponding H37Rv ORFs ICDS0103 and ICDS0105 were full-length in this strain) (see Additional file [1](#S1){ref-type="supplementary-material"}). Noteworthy, was the identification of additional mutations in the vicinity (≤ 200 bp) of the original frameshift (see additional file [1](#S1){ref-type="supplementary-material"}). We next investigated whether the 19 ICDSs common to all *M. tuberculosis s.s*strains were present in the other clinical isolates. In each case, the ICDSs were also present in the three strains (Haarlem, F11, and C), but accompanied, in some cases, by additional mutations in the flanking region (see Additional file [1](#S1){ref-type="supplementary-material"}). Thus, 98 frameshift-containing genes were found to be conserved in all five *M. tuberculosis*strains analyzed.

The recently published *M. bovis*BCG genome sequence is of a particular interest in this respect \[[@B27]\]. This strain, which is currently used for vaccination in humans, was derived from *M. bovis*after 13 years of repetitive passages *in vitro*\[[@B28]\]. A number of genetic differences, such as deletions and duplications had already been identified in the BCG strain \[[@B29],[@B30]\], but large amounts of additional information have now been obtained from its genome sequence. According to our investigation, *M. bovis*BCG 1173P2 contains 127 ICDSs in total, 9 of which are strain-specific (Figure [1B](#F1){ref-type="fig"}). The 81 ICDSs common to the 3 other isolates are also present in this strain (Table [1](#T1){ref-type="table"}) and 35 ICDSs are common to the *M. bovis*strain. We detected frameshift-containing genes in *M. bovis*AF2122/97 that corresponded to full-length ORFs in *M. bovis*BCG 1173P2, suggesting that this *M. bovis*strain is not the direct progenitor of the BCG vaccine (see Additional file [2](#S2){ref-type="supplementary-material"}).

Strain-specific ICDSs reflect newly acquired mutations and are a useful phylogenetic tool
-----------------------------------------------------------------------------------------

Eighty-one ICDSs were common to all three strains, but some were specific to one strain only: 12 for *M. tuberculosis*H37Rv (see Additional file [3](#S3){ref-type="supplementary-material"}), 36 for CDC1551 (see Additional file [4](#S4){ref-type="supplementary-material"}) and 51 for *M. bovis*(see Additional file [2](#S2){ref-type="supplementary-material"}, Figure [1A](#F1){ref-type="fig"}). The proportion of ICDSs that were strain-specific was highly variable. These ICDSs accounted for 10% of all ICDSs in H37Rv, 26% in CDC1551 and 38% in *M. bovis*. The much larger proportion of strain-specific ICDSs in CDC1551 than in H37Rv strain is surprising, and we currently have no reasonable explanation for this phenomenon. A plausible hypothesis is that the genome sequence of CDC1551 strain has not been re-sequenced like the H37Rv genome sequence \[[@B22],[@B28]\]. Strain-specific frameshift-containing genes most likely correspond to mutations acquired after the divergence of these strains. Like the common ICDSs, these events affected genes from several classes, including \"unknown or hypothetical ORFs\", \"intermediary metabolism\" and \"cell wall, process\" (Additional files 2, 3 and 4). As stated above, few of these strain-specific ICDSs may correspond to errors introduced during the sequencing procedure \[[@B4],[@B11]\], but such errors would nonetheless have only a slight effect on the overall outcome of the comparative analysis.

This study shows that the genome sequence of *M. tuberculosis*contains ICDSs that have been acquired during the evolution of this species. The pool of ICDSs can be classified into ICDSs common to a set of strains or species and ICDSs specific to a particular strain-lineage or strain, revealing genetic differences between strains or species.

Using ICDS comparisons to type W-Beijing strains and other *M. tuberculosis*lineages
------------------------------------------------------------------------------------

W-Beijing is a lineage of *M. tuberculosis*that has attracted considerable attention. Indeed, strains of this lineage have been implicated in severe outbreaks and have been shown to have different genetic and phenotypic properties \[[@B20],[@B21],[@B31]\]. The genome of a strain of the W-Beijing family (strain 210) is currently sequenced but not yet fully assembled; nevertheless it can be consulted in homology searches. Consequently the total number of frameshift-containing genes in this species and the full characterization of specific ICDSs remain elusive. It is however possible to screen for the presence of ICDSs in this strain.

We first investigated whether the 81 frameshift-containing genes common to all strains were also present in the genome of strain 210. All 81 of these genes also contained the same frameshift in strain 210, in agreement with the data described above. This suggests that these 81 frameshift mutations were acquired before the divergence of strain 210 from these other strains. We then investigated the 19 genes containing frameshifts common to the five strains of *M. tuberculosis*(H37Rv, CDC1551, Haarlem, F11, C) but not to *M. bovis*. We found that eight of these 19 genes contain no frameshift in strain 210, and hence corresponded to full-length ORFs (Table [2](#T2){ref-type="table"}). Three genes contained frameshifts corresponding to those observed in strains CDC1551, H37Rv, Haarlem, F11 and C, but also contained additional mutations in the corresponding flanks (≤ 200 bp) of the original frameshift (Table [2](#T2){ref-type="table"}). The remaining 11 ICDSs corresponded to frameshift-containing genes common to all six TB strains examined (CDC1551, H37Rv, Haarlem, F11, C, 210) and the events were identical at the molecular level. Thus, the 19 frameshift-containing genes in the two TB strains (CDC1551 and H37Rv) displayed polymorphism in strain 210 and 11 of these identified ICDSs were common to all six TB strains examined. Some of these ICDSs display no further mutation (the gene contains the frameshift alone), whereas others have acquired additional mutations, contributing to the \"pseudogenization\" process (data not shown).

We then investigated the eight ICDSs showing polymorphism in *M. tuberculosis*in 21 strains of the W-Beijing lineage from several phylogenetic groups (Table [3](#T3){ref-type="table"}). The eight loci were amplified by PCR, sequenced and the nucleotide sequence was compared with that of strains 210 and H37Rv. In all W-Beijing strains tested, the eight genes were full-length, with sequences 100% identical to that in strain 210, excepted for the ICDS0085 where a non-disruptive SNP is present in the region. The W-Beijing lineage is therefore a genetically homogeneous group with fewer ICDSs in common with other TB strains.

###### 

Analysis in 21 W-Beijing isolates of the 8 ICDSs of H37Rv strain corresponding to full-length ORFs in W-Beijing strain 210.

                            Finger print   Tracking Number   ICDS 0005   ICDS 0011   ICDS 0031   ICDS 0066   ICDS 0067   ICDS 0072   ICDS 0085   ICDS 0094
  ------------------------- -------------- ----------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
  **W-Beijing**             **W**          **10648**         FL          FL          FL          FL          FL          FL          NT          FL
                            **W**          **565**           FL          FL          FL          FL          FL          FL          FL\*        FL
                            **W4**         **10775**         FL          FL          FL          FL          FL          FL          FL\*        FL
                            **W14**        **3617**          FL          FL          FL          FL          FL          FL          FL\*        FL
                            **W26**        **10270**         FL          FL          FL          FL          FL          FL          FL\*        FL
                            **W69**        **5418**          FL          FL          FL          FL          FL          FL          FL\*        FL
                            **W88**        **7052**          FL          FL          FL          FL          FL          FL          FL\*        FL
                            **W130**       **6707**          FL          FL          FL          FL          FL          FL          FL\*        FL
                            **W148**       **8561**          FL          FL          FL          FL          FL          FL\*        FL\*        FL
                            **W183**       **7657**          FL          FL          FL          FL          FL          FL          NT          FL
                            **W215**       **8963**          FL          FL          FL          FL          FL          FL          FL\*        FL
                            **W342**       **10644**         FL          FL          FL          FL          FL          FL          FL\*        FL
                                                                                                                                                 
  **Ancestral W-Beijing**   **N17**        **3046**          FL          FL          FL          FL          FL          FL          FL\*        FL
                            **LB**         **8128**          FL          FL          FL          FL          FL          FL          FL\*        FL
                            **AR**         **12360**         FL          FL          FL          FL          FL          FL          FL\*        FL
                            **AM**         **4948**          FL          FL          FL          FL          FL          FL          FL\*        FL
                            **CK**         **6595**          FL          FL          FL          FL          FL          FL          FL\*        FL
                            **CN1**        **16116**         FL          FL          FL          FL          FL          FL          FL\*        FL
                            **HE7**        **13454**         FL          FL          FL          FL          FL          FL          FL\*        FL
                            **HI**         **5116**          FL          FL          FL          FL          FL          FL          FL\*        FL
                            **KY**         **10583**         FL          FL          NT          FL          FL          FL          FL\*        FL
                                                                                                                                                 
  **AF/H37 lineage**        **H37Rv**      **ATCC25618**     ICDS        ICDS        ICDS        ICDS        ICDS        ICDS        ICDS        ICDS
                                                                                                                                                 
  ***M. bovis*AF2122/97**                                    FL          FL          FL          FL          FL          FL          FL          FL

*M. tuberculosis*isolates from various lineages for which chromosomal DNA was used as a template for PCR amplification of the selected locus. \"FL\" indicates the presence of a full-length ORF identical to that in the *M. tuberculosis*210 strain, \"\*\" indicates an additional mutation acquired in these isolates with respect to *M. tuberculosis*H37Rv, \"NT\", not tested.

To extend our analysis, we investigate the *M. africanum*strain, which is currently sequenced at the Sanger centre. Similarly to *M. tuberculosis*210 strain, the *M. africanum*genome is still at the assembly step, but can be nevertheless consulted on line. We investigated whether the 81 frameshift containing genes common to all strains tested were also present in the *M. africanum*strain (Table [1](#T1){ref-type="table"}). All 81 of these genes also contained a frameshift in *M. africanum*, which suggests that these mutations were acquired before the divergence of the *M. tuberculosis*complex. We then investigated the 19 genes containing frameshift common to the 5 *M. tuberculosis*strains (CDC1551, H37Rv, Haarlem, F11, C). We found that 15 out of these 19 genes were deprived of the frameshift in *M. africanum*and corresponded to full-length ORFs in this strain (Table [2](#T2){ref-type="table"}). Eight out of these 15 genes match the wild-type ORFs identified in *M. tuberculosis*strain 210 and other strains of the W-Beijing lineage. In conclusion, the genome of *M. africanum*contains fewer ICDSs in common with the other TB isolates (CDC1551, H37Rv, Haarlem, F11, C) than with the W-Beijing strain and seems genetically closer to this lineage.

ICDS formation is not correlated with mutation in the promoter region
---------------------------------------------------------------------

It has been suggested that pseudogene formation is associated with mutations in the upstream untranslated region, abolishing pseudogene expression to prevent a loss of metabolic function \[[@B32]\]. Once turned off, the gene continues to accumulate mutations, leading to complete pseudogene formation. ICDSs are not pseudogenes in the strict sense of the word. Indeed, the ORF is split into only two or three unframed fragments and can, in theory, revert to a wild-type allele. ICDSs are therefore considered to be ORFs undergoing \"pseudogenization\" rather than pseudogenes *per se*. Strain-specific ICDSs are, by definition, genes that are mutated in one strain, but not in another. We therefore investigated whether ICDS formation was correlated with mutation in the promoter region. All the intergenic regions (99) located upstream from strain-specific ICDSs of *M. tuberculosis*H37Rv, CDC1551 and *M. bovis*were compared with the corresponding region in the two strains having a wild-type gene. We used as a control the promoter region of randomly selected genes that are full-length in these 3 strains. We compared the level of differences observed in the promoter regions of genes full-length or containing frameshift. Nucleotide differences were observed in 27% of the upstream region of genes containing frameshift (see Additional file [5A](#S5){ref-type="supplementary-material"}), while 20% was observed in the case of the full-length genes (see Additional file [5B](#S5){ref-type="supplementary-material"}), which is not statistically significant using the chi square test. In all but 6 cases for ICDS and 2 cases for full-length genes, the difference in the upstream region was limited to one or two SNPs.

We therefore conclude that ICDS formation is not correlated with mutation in the untranslated upstream region and suggest that either promoter mutations do not play a major role in pseudogene formation in the *M. tuberculosis*complex or that \"pseudogenization\" is recent.

Discussion
==========

The presence of frameshift-containing genes in bacterial genomes is well documented \[[@B1]-[@B3],[@B33]\]. A few species can bypass such frameshifts, but most do not, generally resulting in a loss of function.

We show here that ICDSs can be classified as \"common to all strains\" or \"strain-specific\". The ICDSs common to all strains probably correspond to mutations acquired before the divergence of the strains, whereas strain-specific ICDSs correspond to those acquired subsequently (Figure [2](#F2){ref-type="fig"}). Mutations acquired after the speciation of *M. tuberculosis*from *M. bovis*were also detected. We identified 19 ICDSs common to the five *M. tuberculosis*strains (H37Rv, CDC1551, Haarlem, F11 and C) but not to *M. bovis*, about one-fifth of ICDSs common to all strains. Comparative analyses of ICDSs help to characterize the phylogenetic relationships between highly related strains and species (Figure [2](#F2){ref-type="fig"}) and could be applied to any bacterial species for which several genome sequences are available. In few cases, ICDSs may correspond to fusion/fission of orthologous genes in other genomes. The detection of this kind of events is due to the method of identification of ICDS but remains however a minor inconvenience \[[@B3]\]. It is however possible that a low percentage of specific ICDSs does correspond to sequencing errors, inducing thus artifactual phylogenetic relationships. Researchers should resequence these regions before assuming that the ICDS corresponds to a frameshift acquisition. Several studies have compared the genome sequences of *M. tuberculosis*CDC1551 and H37Rv, using high-resolution genomics techniques \[[@B18]\]. This has led to the definition of regions containing large-sequence polymorphisms (LSPs, greater than 10 bp) and single nucleotide polymorphisms (SNPs). The SNPs have been investigated in more detail in various clinical isolates, to draw up a global phylogeny of *M. tuberculosis*\[[@B17]\]. Other molecular methods, such as analyses of the deleted regions (deligotyping), variable numbers of tandem repeats (VNTR), mycobacterial interspersed repetitive unit (MIRU) and spoligotyping, have helped to unravel global genomic sequence diversity in this species \[[@B34]-[@B36]\]. These techniques are highly useful for epidemiological studies, but as far provide little information pertaining to genetic differences in terms of putative function. In contrast, studies of regions of deletion (RD) have proved useful for both global phylogeny and study of a loss of phenotype in both *M. tuberculosis*and in *M. ulcerans*\[[@B25],[@B30],[@B37]\].

![Hypothetical phylogenetic links assessed by comparative analyses of ICDSs. In this schematic representation, the common ancestor gave rise to several branches of strains of the TB complex. Eighty-one frameshifts were acquired during the common evolution of *M. bovis*and *M. tuberculosis*. Since the separation of these species, *M. bovis*has acquired 51 frameshifts, while the branch leading to *M. tuberculosis*isolates has acquired 19 new frameshifts. Since separation of the isolates, *M. tuberculosis*H37Rv has acquired 12 new frameshifts and CDC1551 36 new frameshifts. Common and unique ICDSs are shown in dark and light gray, respectively. \"\*\" these 8 ICDSs correspond to full-length ORF in *M. tuberculosis*210 and in *M. africanum*GM041182. \"\*\*\" 7 out of these 11 ICDSs correspond to full-length ORF in *M. africanum*GM041182 (Table 2).](1471-2148-8-78-2){#F2}

Frameshift acquisition generally leads to a loss of function, as shown in a number of published studies. Loss-of-function associated with the presence of a frameshift has been reported in both *M. tuberculosis*and *M. bovis*. For instance, ICDS0066 in *M. tuberculosis*H37Rv corresponds to a frameshift-containing gene encoding a polyketide synthase (*pks1*). This *pks1*gene also contains a frameshift in *M. tuberculosis*CDC1551, resulting in two different ORFs: *pks1*and *pks15*. In contrast, *M. bovis*and *M. leprae*carry a full-length functional *pks1*gene \[[@B38]\]. The *pks15/1*gene is now frequently used as a marker in epidemiological studies \[[@B39],[@B40]\] and, interestingly, the *pks*gene contains no frameshift in the W-Beijing strains of *M. tuberculosis*\[[@B40]\], resulting in phenolglycolipid production in most cases \[[@B41]\]. Our analysis shows that the *pks*gene of *M. africanum*is also full-length suggesting that this species produces PGL. This observation suggests that these early strains are more closely related to *M. bovis*or to the last ancestor than other *M. tuberculosis*strains. Similarly, ICDS0067 in *M. bovis*corresponds to a putative frameshift-containing glycosyltransferase gene. The ortholog of this gene has no frameshift in the two strains of *M. tuberculosis*(Rv2958c and MT3034). Functional complementation of *M. bovis*BCG with the Rv2958c gene from *M. tuberculosis*leads to the accumulation of a new metabolite, the diglycosylated phenolglycolipid \[[@B42]\]. Some frameshift-containing genes have been studied experimentally in *M. tuberculosis*, without considering the possibility that these ORFs may well contain frameshift \[[@B43],[@B44]\]. Mutation by homologous recombination has been achieved at the *mntH*and *mmpL13*loci. In both cases, no detectable phenotype was associated with the mutation. Our data indicate that MmpL13 function should be investigated in a W-Beijing strain or in *M. africanum*. Another example that has not yet been studied is the *pks3*and *pks4*genes of *M. tuberculosis*H37Rv, which constitute a single ORF in CDC1551 and in *M. bovis*. This suggests that -- like the *pks1*and *pks15*genes, which are pseudogenes in *M. tuberculosis*-- the *pks3*and *pks4*genes are probably not functional in the H37Rv strain. It would therefore be pointless to investigate function in the H37Rv strain by creating mutants in *pks3*and *pks4*genes or by expressing constructs encoding the corresponding polypeptides. These examples from previous publications illustrate the major biological impact of frameshift acquisition. They demonstrate the importance of choosing the right strain or species for investigations of the function of a particular gene. However, it is not always possible to infer from the position of the frameshift whether the protein\'s activity will be affected. For instance, GlnA3, a glutamine synthetase generated from a frameshift-containing gene (Table [1](#T1){ref-type="table"}), has been purified and shown to retain some activity \[[@B45]\]. It would be interesting to reframe these ORFs to test the impact of frameshift on protein function. On the other hand, it has been shown *in silico*that protein-coding sequences can be tolerant of frameshift translation events and thus that frameshit acquisition is an important reservoir for creating novel proteins \[[@B46]\]. Several of the truncated ORFs described here have also been detected in other studies, based on different analyses \[[@B17],[@B18],[@B40],[@B47],[@B48]\]. However, we present here a comprehensive comparative analysis of three related mycobacterial species and nine strains at the ICDS level.

We found no association between ICDS formation and mutation in the promoter region of the corresponding ORF. This suggests that promoter mutation and inactivation of gene expression are not the principal source of ICDS formation and hence of pseudogene accumulation in the *M. tuberculosis*complex. It may also suggest that ICDS formation in these species is a recent process. We favor the hypothesis that ORFs are first split into two or three parts, inactivating their function, and are then subject to secondary mutation (in both the ICDS and the untranslated region), leading to irreversible pseudogene fixation. Consistent with this hypothesis, we have observed additional mutations in the vicinity of the original frameshift in some strains.

We have shown that ICDS investigation can be used to infer the evolutionary relationships between strains and species. We provide here a list of more than 150 ICDSs that may be useful for characterizing TB strains and inferring phylogenetic relationships. The genome sequences of more than 10 TB strains will be released in the near future \[[@B26]\], and will, by no doubt, identify some new common and strain-specific ICDSs. Strain typing should clearly combine various markers, such as SNPs, MIRU, LSPs, RD, PE polymorphism \[[@B49]\] and ICDSs, in a matrix-based comparison from which the global phylogeny of TB isolates may be deduced. The polymorphism associated with these mutations is complementary to other methods \[[@B17],[@B34],[@B36],[@B37],[@B50]\], hence can be used to explore genetic diversity within a given species. Interestingly, in strain 210, from the W-Beijing family, eight of the 19 ICDSs common to the five *M. tuberculosis*strains tested (H37Rv, CDC1551, Haarlem, F11, C) corresponded to full-length ORFs, illustrating its earlier divergence. Some of these genes may be involved in virulence, as they concern functions such as host cell invasion (ICDS0011 of H37Rv), lipid biosynthesis (ICDS0066 and ICDS0031 of H37Rv) and intermediary metabolism (ICDS0085 of H37Rv). To test whether this trait was a particularity of the 210 strain or applied more generally to the W-Beijing phylum, we sequenced these eight ORF that were full-length in this strain in 21 other clinical isolates of the W-Beijing (Table [3](#T3){ref-type="table"}). In all cases, the ORF were corresponding to a full-length ORF and not to an ICDS, demonstrating that these strains are genetically homogenous. The analysis performed using a strain of *M. africanum*showed that this species is characterized by an even fewer number of ICDSs common to *M. tuberculosis*H37Rv and CDC1551 than to the W-Beijing strains. More genome sequences of various strains and species are required for characterization of the genetic differences between the W-Beijing strains and other species of the *M. tuberculosis*complex. The *alkA*gene has been shown to contain frameshift in both *M. bovis*and some *M. tuberculosis*isolates from Central African Republic \[[@B48]\]. The presence of SNPs in the adjacent region of the non-sense mutation has led the authors to propose a convergent evolution. Although, it probably depends from genes to genes, we instead favor the hypothesis that the non-sense mutation was acquired by the ancestor and spread to the progeny with acquisition of subsequent mutations in the adjacent region. Epidemiologists should bear in mind that a small percentage of ICDSs may correspond to sequencing errors \[[@B4],[@B11]\], generating artifactual genetic differences. Our analysis did not allow for the detection of mutations in which the frame of the coding sequence was conserved (synonymous mutation, in frame deletion), decreasing the total level of diversity observed. However, comparative ICDS analysis presents the major advantage of making it possible to associate the frameshift with a putative function and, possibly, with a particular phenotype. In conclusion, more attention should be paid to ICDS detection and comparison, particularly at the genomic scale.

Conclusion
==========

We report here a comparative analysis of ICDSs in six isolates of *M. tuberculosis*, two of *M. bovis*and one of *M. africanum*. We show that these ICDSs can be classified as \"common to all strains\" or \"strain-specific\". Common ICDSs result from mutations acquired before the divergence of the species, whereas strain-specific ICDSs were acquired after this divergence. Comparative analyses of these ICDSs allow the definition of the molecular signature of a particular strain, phylogenetic lineage or species. We further show that ICDS formation is not correlated with the presence of a mutated promoter, and suggest that promoter extinction is not the main cause of pseudogene formation. The correlation between ICDSs, function and phenotypes could have important evolutionary implications and provides population geneticists with a list of targets, which could undergo selective pressure and thus alters relationships between the various lineages of *M. tuberculosis*strains and their host.

Methods
=======

Databases
---------

The genome sequences of *M. tuberculosis*H37Rv and CDC1551 and *M. bovis*AF2122/97 were taken from TIGR website \[[@B51]\]. The genome sequences of *M. tuberculosis*strains 210 or F11, C and Haarlem have been consulted on the TIGR or Broad Institute websites \[[@B52]\]. The genome sequence of *M. bovis*BCG 1173P2 has been taken from National Center for Biotechnology Information (NCBI) website (accession number, AM408590). The genome sequence of *M. africanum*GM041182 was consulted on line at the Sanger centre \[[@B53]\].

Detection of common ICDS
------------------------

The genomic sequences of *M. tuberculosis*CDC1551, *M. tuberculosis*H37Rv, *M. bovis*AF2122/97 and *M. bovis*BCG 1173P2 have been scanned for couple of adjacent coding sequences that exhibit common homologs after translation. Such pair of coding sequences is considered as an ICDS if no paralogy relationship exists between the two coding sequences. The detailed description of ICDS detection is described in \[[@B3]\]. The ICDSs detected in each strain were then cross-compared by all-against-all blastn searches. For each ICDS, the best hits (E \< 10^-65^) detected in the different strains were manually analysed to discriminate common and strain-specific ICDS.

Sequencing analysis
-------------------

Chromosomal DNA of *M. tuberculosis*isolates from various lineages (Table [3](#T3){ref-type="table"}) was used as a template for PCR amplification of the selected locus. The primers used to amplify and sequence were designed as previously described \[[@B3]\], using an optimized version of CADO4MI \[[@B54]\]. The nucleotide and deduced amino-acid sequences were analyzed with DNA Strider \[[@B55]\].

Promoter analysis
-----------------

A region of 200 bp upstream the initiation codon was extracted for each of the 99 ICDSs specific to *M. tuberculosis*H37Rv, CDC1551 and *M. bovis*AF2122/97 (Additional files 2, 3 and 4). As a control group, 200 bp upstream the initiation codon was extracted for 99 genes (full-length) randomly selected from *M. tuberculosis*H37Rv. These 99 genes are full-length in *M. tuberculosis*H37Rv, CDC1551 and *M. bovis*AF2122/97. In each case (promoter to be tested and control group), the promoter regions of the 3 strains were aligned using ClustalW \[[@B56]\] and the sequence variation was recorded. The number of differences observed in the upstream region was statistically compared using the Chi2 test.

Statistical analysis
--------------------

The statistical significance of the distribution of the frequency of sequence polymorphism observed in the upstream ICDS regions and upstream full-length regions, was tested using a Chi square test (X^2^). The chi square test is used to determine relationship between two distributions. The calculated values were obtained: X^2^: 1,367, df: 1, P value: 0.2423, hence the difference between 2 groups are not statistically significant (α \< 0.05).

Abbreviations
=============

ICDS, Interrupted CoDing Sequence. ORF, Open Reading Frame.
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